Bank of America’s Clovis Oncology, Inc. CLVS Stock Holding History

Bank of America’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200,000	Closed	-$238K	–	8619
2022 Q3	$238K	Hold	200,000	–	–	﹤0.01%	5883
2022 Q2	$360K	Hold	200,000	–	–	﹤0.01%	5662
2022 Q1	$404K	Hold	200,000	–	–	﹤0.01%	5983
2021 Q4	$542K	Buy	+200,000	New	+$739K	﹤0.01%	5794
2020 Q1	–	Sell	-20,000	Closed	-$209K	–	7401
2019 Q4	$209K	Buy	+20,000	New	+$145K	﹤0.01%	5615
2019 Q2	–	Sell	-75,700	Closed	-$1.88M	–	7517
2019 Q1	$1.88M	Sell	75,700 -5,300	-7%	-$133K	﹤0.01%	4038
2018 Q4	$1.46M	Buy	81,000 +31,100	+62%	+$635K	﹤0.01%	4107
2018 Q3	$1.47M	Hold	49,900	–	–	﹤0.01%	4209
2018 Q2	$2.27M	Hold	49,900	–	–	﹤0.01%	3882
2018 Q1	$2.63M	Buy	49,900 +44,900	+898%	+$2.62M	﹤0.01%	3662
2017 Q4	$340K	Sell	5,000 -218,300	-98%	-$15.3M	﹤0.01%	5153
2017 Q3	$18.4M	Buy	223,300 +62,500	+39%	+$4.95M	﹤0.01%	1956
2017 Q2	$15.1M	Sell	160,800 -49,200	-23%	-$3.01M	﹤0.01%	1987
2017 Q1	$13.4M	Buy	+210,000	New	+$12.8M	﹤0.01%	2122
2016 Q2	–	Sell	-75,000	Closed	-$1.44M	–	7482
2016 Q1	$1.44M	Buy	+75,000	New	+$1.59M	﹤0.01%	3844

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Bank of America's CLVS Position: Q4 2022 in Review

Bank of America sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 10,958 shares — an estimated $13K sold.

Bank of America first reported a position in CLVS in Q2 2013 and held it in 38 quarters. The position peaked at $60.6M in Q2 2017. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Bank of America reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Bank of America sold 10,958 Clovis Oncology, Inc. shares in Q4 2022, an estimated $13K.
Bank of America first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 38 quarters.
Bank of America's Clovis Oncology, Inc. position peaked at $60.6M in Q2 2017.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Bank of America's 13F filing for Q4 2022, filed 10 Feb 2023.